The role of vaspin as a predictor of coronary angiography result in SCAD (stable coronary artery disease) patients
Open Access
- 8 May 2017
- journal article
- research article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 17 (1) , 1-9
Abstract
The role of vaspin in the pathogenesis of stable coronary artery disease (SCAD) have been repeatedly addressed in clinical studies. However, from the point of view of clinical practice, the results of earlier studies are still inconclusive. The data of 106 SCAD patients who received coronary angiography and 85 coronary artery disease-free controls were collected and analysed. The patients were divided into subgroups according to their pre-test probability (PTP) and according to the result of coronary angiography. Fasting vaspin concentrations were compared between subgroups of SCAD patients and between target group and controls. The effect of age and smoking on the result of coronary angiography was compared to the effect of vaspin using the binomial regression. We did not find significant difference in vaspin level between target group and controls. Unless the pre-test probability was taken into account, we did not find vaspin difference in the target group, when dividing patients on the basis of presence/absence of significant coronary stenosis. In the subgroup of SCAD patients with PTP between 15% – 65%, those with significant coronary stenoses had higher mean vaspin concentration (0,579 ± 0,898 ng/ml) than patients without significant stenoses. (0,379 ± 0,732 ng/ml) (t = −2595; p = 0,012; d = 0,658; 1-β = 0,850). Age, smoking status and vaspin significantly contributed to the HSCS prediction in binomial regression model in patients with low PTP (OR: 1.1, 4.9, 8.7, respectively). According to our results, vaspin cannot be used as an independent marker for the presence of CAD in general population. However, our results indicate that measuring vaspin in SCAD patients might be clinically useful in patients with PTP below 66%.Keywords
Funding Information
- SRDA (Slovak Research and Development Agency) (APVV – 14 – 0153)
- VEGA (scientific grant agency of the Ministry of Education of the Slovak Republic) (VEGA 1/0160/16)
This publication has 16 references indexed in Scilit:
- Visceral Adipose Tissue-derived Serine Proteinase Inhibitor Inhibits Apoptosis of Endothelial Cells as a Ligand for the Cell-Surface GRP78/Voltage-dependent Anion Channel ComplexCirculation Research, 2013
- Vaspin inhibits kallikrein 7 by serpin mechanismCellular and Molecular Life Sciences, 2013
- Vaspin Increases Nitric Oxide Bioavailability through the Reduction of Asymmetric Dimethylarginine in Vascular Endothelial CellsPLOS ONE, 2012
- Vaspin Is an Adipokine Ameliorating ER Stress in Obesity as a Ligand for Cell-Surface GRP78/MTJ-1 ComplexDiabetes, 2012
- Genetic variation in the vaspin gene affects circulating serum vaspin concentrationsInternational Journal of Obesity, 2012
- The Investigation of Serum Vaspin Level in Atherosclerotic Coronary Artery DiseaseJournal of Clinical Medicine Research, 2012
- Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in womenClinical Endocrinology, 2011
- Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effectsDiabetologia, 2011
- Serum levels of vaspin and visfatin in patients with coronary artery disease—Kozani studyClinica Chimica Acta, 2011
- Combined effects of body mass index and cardio/respiratory fitness on serum vaspin concentrations in Korean young menEuropean Journal of Applied Physiology, 2009